Genoskin
PrivateLast Round
Debt
Sep 16, 2025
Total Funding Raised
$10.34M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genoskin operates in Healthcare & Life Sciences and is based in Toulouse. Its latest recorded funding round was a Debt round in September 2025.
Genoskin is a biotechnology company that provides ready-to-use, live human skin models for pharmaceutical, cosmetic, and chemical product testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genoskin Comparables
Compare Genoskin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CTIBiotech | 84% | |
| Alcyomics | 83% | |
| Hesperos Inc. | 83% |
For institutional investors. Book with your work email.
Genoskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 16, 2025 | ||||
| Series A | Sep 16, 2025 | ||||
| Grant | Oct 28, 2020 | ||||
| Grant | Aug 29, 2019 | ||||
| Grant | Mar 7, 2018 | ||||
Early Funding | Aug 29, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genoskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GSO Innovation | Series A |
| European Regional Development Fund | Grant |
| Finorpa | Series A |
| Région Occitanie | Grant |
| CA Toulouse 31 Initiatives | Series A |
| Caisse d'Epargne Midi-Pyrénées | Debt, Series A |
| OCCTE | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 219% MoM, reaching 15.7K.
- Apr 27, 2026
Fabrice Bouteille appointed to strengthen governance.
For institutional investors. Book with your work email.
Genoskin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genoskin's valuation, stock price, and market status.
Is Genoskin a public or private company?
Genoskin is a private company.
What is the current stock price of Genoskin?
Genoskin is a private company, so its shares have no public market price. Caplight tracks Genoskin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genoskin worth (valuation)?
Valuation information for Genoskin is not publicly available.
Can I buy Genoskin stock?
Genoskin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genoskin's last funding round?
Genoskin's most recent funding round was Debt on September 16, 2025.
Who are the main investors in Genoskin?
Key investors in Genoskin include OCCTE.
Will Genoskin IPO soon?
No public IPO plans have been announced for Genoskin.
How can I track Genoskin secondary market activity?
Caplight tracks bids, offers, and trades in Genoskin's shares on secondary markets.